Bilateral Erector Spinae Plane Block for Myofascial Pain Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-25

Study Completion Date

2022-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators aimed to evaluate the effectiveness of bilateral erector spina plane block application in myofascial pain syndrome.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Contribution of Erector Spina Plane Block to Analgesia for Myofascial Pain Syndrome

NCT04405453

Trigger Point Myofascial Pain

COMPLETED NA

Comparison of the Efficacy of Rhomboid Intercostal Block and Erector Spinal Plane Block on Myofascial Pain Syndrome

NCT05073900

Myofascial Pain Syndrome

COMPLETED NA

Effectiveness of Serratus Posterior Superior Intercostal Plane Block Applied With Ultrasonography in Myofascial Pain Syndrome

NCT06557993

Pain, Neck

RECRUITING

Erector Spina Plane Block and Radiofrequency Treatmen

NCT05888285

Back Pain Block Pain, Muscle

COMPLETED NA

Erector Spinae Plane Block in Spine Surgeries

NCT05247021

Lumbar Disc Disease

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators aimed to evaluate the effectiveness of bilateral erector spina plane block application in myofascial pain syndrome by comparing trigger point injection. Group 1 only one time erector spinae plane block and group 2 once a week total three times trigger point injection. Before the application, one week after application and one month after first application the investigators aimed to compare pressure pain threshold with algometer, visual analog scale score, short form-36 score, neck disability index score, beck depression scale score for the two groups. Each group has 30 participants, total 60 participants included this study. The investigators planned to show that bilateral erector spinae plane block can be used as an effective and safe method in the treatment of myofascial pain syndrome, since it is easier to apply than other invasive procedures used in the treatment and has a very low complication profile.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myofascial Pain Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Comparing the efficacy of erector spina plan block and trigger point injection in patients with myofascial pain syndrome

Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bilateral Erector Spinae Plane Block

Group Type ACTIVE_COMPARATOR

Bilateral thoracal erector spinae plane block

Intervention Type PROCEDURE

Bilateral upper thoracal erector spinae plane block with ultrasound

Trigger Point Injection

Trapezius muscle Trigger Point Injection

Group Type ACTIVE_COMPARATOR

Trapezius muscle trigger point injection

Intervention Type PROCEDURE

Trapezius muscle trigger point injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bilateral thoracal erector spinae plane block

Bilateral upper thoracal erector spinae plane block with ultrasound

Intervention Type PROCEDURE

Trapezius muscle trigger point injection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Get a myofascial pain syndrome diagnosis
* No invasive procedure for myofascial pain syndrome in the last 1 month
* Signing the informed consent form

Exclusion Criteria

* Cervical disc herniation
* Neck/shoulder, thoracal trauma or operation history
* Malignancy
* Kyphoscoliosis
* Inflammatory diseases (Rheumatoid arthritis, ankylosing spondylitis...)
* Congenital vertebral anomalies
* Neck pain with neurological deficit
* Pregnancy
* Mental, psychogenic disorder
* Hematological diseases that cause bleeding and coagulation disorders
* Use of antiplatelet, anticoagulant and drugs that cause bleeding tendency
* Severe systemic infection such as sepsis and local infection at the intervention site
* Having an allergy to any of the drugs to be used

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No